Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID

Affiliation auteursAffiliation ok
TitreVedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID
Type de publicationJournal Article
Year of Publication2018
AuteursCaron B., Peyrin-Biroulet L., Nachury M., Bouhnik Y., Seksik P., Bouguen G., Caillo L., Laharie D., Carbonnel F., Altwegg R., Reenaers C., Serrero M., Boureille A., Nancey S., Filippi J., Abitbol V., Savoye G., Vuitton L., Viennot S., Fumery M., Reymond M., Bronowicki J.P, Reimund J.-M, Amiot A.
JournalJOURNAL OF CROHNS & COLITIS
Volume12
PaginationS278
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN1873-9946